RPRX · Royalty Pharma plc · Investor Relations
$68.44
-0.24 (-0.35%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$39.40B
Shares
573.61M
Volume · Nov 18
539.86K
Avg daily vol (3M)
3.17M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-11-04 | Royalty Pharma reports third quarter 2026 results |
| 2026-10-16 | Royalty Pharma declares fourth quarter 2026 dividend |
| 2026-10-09 | Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026 |
Past events
Key facts
CIK
1802768
CUSIP
G7709Q104
13F (30d)
687 filings
645 filers
Visit website
Investor relations